Institut Curie Enhances Proton Therapy Services
Institut Curie, a prestigious center for cancer treatment, has made a significant stride in enhancing its proton therapy capabilities by integrating the advanced treatment planning system, RayStation, from RaySearch Laboratories AB (publ). This decision marks a pivotal step in elevating the quality of care provided at their various radiotherapy centers.
RayStation's Advanced Features for Oncology
With the implementation of RayStation, Institut Curie will gain access to cutting-edge technology. This includes features like linear energy transfer (LET) optimization, adaptive planning, and artificial intelligence (AI) autocontouring. Such advancements are beneficial for both proton and photon treatment planning.
Proton Therapy Center Support
RayStation is specifically supporting the Institut Curie Proton Therapy Center located in Orsay. This facility is one of three dedicated proton therapy centers in the country, now equipped with the latest in treatment planning technology, thereby expanding the potential for more effective patient treatment outcomes.
Partnership and Collaboration
RaySearch’s founder and CEO, Johan Löf, expressed pride in this collaboration. He acknowledges Institut Curie's strong reputation in the medical field and is eager to deepen the partnership to foster fruitful collaboration. This relationship signifies a commitment to improving patient care through technological advancements.
Investment and Future Prospects
The total order value for this engagement stands at approximately 1.7 million euros, not counting ongoing service agreements. The majority of this revenue was recognized during the third quarter of the financial year 2024. This investment underscores Institut Curie's dedication to remaining at the forefront of cancer treatment technologies.
Contact Information for Further Queries
For additional information about this collaboration or RayStation, interested parties can contact Johan Löf, the CEO of RaySearch Laboratories AB (publ). While the official communication channels remain available, it is crucial to explore how this partnership will unfold in the realm of proton therapy.
Frequently Asked Questions
1. What is RayStation used for?
RayStation is utilized for advanced treatment planning in both proton and photon therapy, optimizing the delivery of radiation in cancer treatments.
2. Why did Institut Curie choose RayStation?
Institut Curie selected RayStation for its advanced features, including adaptive planning and AI autocontouring, which enhance treatment accuracy and effectiveness.
3. Where is the Institut Curie Proton Therapy Center located?
The Institut Curie Proton Therapy Center is located in Orsay, France, one of three such centers in the country utilizing RayStation technology.
4. What is the significance of the 1.7 MEUR order value?
The order value of approximately 1.7 million euros reflects Institut Curie's investment in state-of-the-art treatment planning technology to improve cancer care.
5. Who can I contact for more details regarding the partnership?
For further inquiries, please reach out to Johan Löf, the CEO of RaySearch Laboratories AB (publ), who is the primary contact for this collaboration.
